BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36441968)

  • 41. The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients.
    Campanale A; Spagnoli A; Lispi L; Boldrini R; Marletta M
    Plast Reconstr Surg; 2020 Nov; 146(5):530e-538e. PubMed ID: 32852469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018.
    McCarthy CM; Loyo-Berríos N; Qureshi AA; Mullen E; Gordillo G; Pusic AL; Ashar BS; Sommers K; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S. PubMed ID: 30817558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European Attitudes and Outcomes Regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Multinational Survey.
    Villarroya-Marquina I; Moshrefi S; Sheckter C; Lee GK
    Aesthetic Plast Surg; 2020 Oct; 44(5):1387-1395. PubMed ID: 32367324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
    Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
    Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?
    Groth AK; Clemens MW; Graf R; Sebastião AP; Azambuja AP; Louveira MH; Urban LABD; Batista BN
    Plast Reconstr Surg; 2022 Nov; 150(5):970e-978e. PubMed ID: 35994334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 22 Cases of Breast Implant-Associated ALCL: Awareness and Outcome Tracking from the Italian Ministry of Health.
    Campanale A; Boldrini R; Marletta M
    Plast Reconstr Surg; 2018 Jan; 141(1):11e-19e. PubMed ID: 29280858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
    Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?
    Santanelli di Pompeo F; Sorotos M; Clemens MW; Paolini G; Anibaldi P; Davoli M; Baglio G; Pinnarelli L; Ferranti M; Cerza F; Cicala SD; Firmani G
    Aesthetic Plast Surg; 2023 Jun; 47(3):914-926. PubMed ID: 36376583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Macrotextured Implant Recall: Breast Implant-Associated-Anaplastic Large Cell Lymphoma Risk Aversion in Cosmetic and Reconstructive Plastic Surgery Practices.
    Mankowski P; Carr M; Cherukupalli A; Bovill E; Lennox P; Brown MH; Carr N
    Aesthet Surg J; 2022 Dec; 42(12):1408-1413. PubMed ID: 35709374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
    Kadin ME; Xu H; Hunsicker LM; Guan Y
    Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.
    Vittoria L; Sala L; Summo V; Capone I; Conca E; Toma M; Ottolenghi J; Testa F; Cortinovis U; Paolini B; Cabras A; Aiello A; Bozzi F
    Tumori; 2023 Oct; 109(5):458-465. PubMed ID: 36942354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.
    Santanelli di Pompeo F; Clemens MW; Atlan M; Botti G; Cordeiro PG; De Jong D; Di Napoli A; Hammond D; Haymaker CL; Horwitz SM; Hunt K; Lennox P; Mallucci P; Miranda RN; Munhoz AM; Swanson E; Turner SD; Firmani G; Sorotos M
    Aesthet Surg J; 2022 Oct; 42(11):1262-1278. PubMed ID: 35639805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Sieber DA; Adams WP
    Aesthet Surg J; 2017 Sep; 37(8):887-891. PubMed ID: 29036945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Dutch Breast Implant Registry: Registration of Breast Implant-Associated Anaplastic Large Cell Lymphoma-A Proof of Concept.
    Becherer BE; de Boer M; Spronk PER; Bruggink AH; de Boer JP; van Leeuwen FE; Mureau MAM; van der Hulst RRJW; de Jong D; Rakhorst HA
    Plast Reconstr Surg; 2019 May; 143(5):1298-1306. PubMed ID: 31033810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Updated Report 2012-2020.
    McCarthy CM; Roberts J; Mullen E; Loyo-Berrios N; Clemens MW; Yoon SW; Levinson H; Sommers K; Hume K; Carr L
    Plast Reconstr Surg; 2023 Oct; 152(4S):16S-24S. PubMed ID: 36995215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    O'Neill AC; Zhong T; Hofer SOP
    Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Prospective Approach to Inform and Treat 1340 Patients at Risk for BIA-ALCL.
    Roberts JM; Carr LW; Jones A; Schilling A; Mackay DR; Potochny JD
    Plast Reconstr Surg; 2019 Jul; 144(1):46-54. PubMed ID: 31246798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.